BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 20232757)

  • 1. Prevalence of anaemia in HIV-infected children at the University of Abuja Teaching Hospital, Gwagwalada.
    Okechukwu AA; Gambo D; Okechukwu IO
    Niger J Med; 2010; 19(1):50-7. PubMed ID: 20232757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Haematological changes after switching from stavudine to zidovudine in HIV-infected children receiving highly active antiretroviral therapy.
    Aurpibul L; Puthanakit T; Sirisanthana T; Sirisanthana V
    HIV Med; 2008 May; 9(5):317-21. PubMed ID: 18331562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Haematological changes in adults receiving a zidovudine-containing HAART regimen in combination with cotrimoxazole in Côte d'Ivoire.
    Moh R; Danel C; Sorho S; Sauvageot D; Anzian A; Minga A; Gomis OB; Konga C; Inwoley A; Gabillard D; Bissagnene E; Salamon R; Anglaret X
    Antivir Ther; 2005; 10(5):615-24. PubMed ID: 16152755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of stavudine, didanosine and indinavir with zidovudine, lamivudine and indinavir for the initial treatment of HIV-1 infected individuals: selection of thymidine analog regimen therapy (START II).
    Eron JJ; Murphy RL; Peterson D; Pottage J; Parenti DM; Jemsek J; Swindells S; Sepulveda G; Bellos N; Rashbaum BC; Esinhart J; Schoellkopf N; Grosso R; Stevens M
    AIDS; 2000 Jul; 14(11):1601-10. PubMed ID: 10983647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anaemia and zidovudine-containing antiretroviral therapy in paediatric antiretroviral programmes in the IeDEA Paediatric West African Database to evaluate AIDS.
    Renner LA; Dicko F; Kouéta F; Malateste K; Gueye RD; Aka E; Eboua TK; Azondékon A; Okomo U; Touré P; Ekouévi D; Leroy V;
    J Int AIDS Soc; 2013 Sep; 16(1):18024. PubMed ID: 24047928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of adipokine expression and mitochondrial toxicity in HIV patients with lipoatrophy on stavudine- and zidovudine-containing regimens.
    Jones SP; Qazi N; Morelese J; Lebrecht D; Sutinen J; Yki-Jărvinen H; Back DJ; Pirmohamed M; Gazzard BG; Walker UA; Moyle GJ
    J Acquir Immune Defic Syndr; 2005 Dec; 40(5):565-72. PubMed ID: 16284533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High incidence of zidovudine induced anaemia in HIV infected patients in eastern India.
    Agarwal D; Chakravarty J; Chaube L; Rai M; Agrawal NR; Sundar S
    Indian J Med Res; 2010 Oct; 132():386-9. PubMed ID: 20966515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of stavudine plus lamivudine versus zidovudine plus lamivudine in combination with indinavir in antiretroviral naive individuals with HIV infection: selection of thymidine analog regimen therapy (START I).
    Squires KE; Gulick R; Tebas P; Santana J; Mulanovich V; Clark R; Yangco B; Marlowe SI; Wright D; Cohen C; Cooley T; Mauney J; Uffelman K; Schoellkopf N; Grosso R; Stevens M
    AIDS; 2000 Jul; 14(11):1591-600. PubMed ID: 10983646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical correlate of tuberculosis in HIV co-infected children at the University of Abuja Teaching Hospital, Gwagwalada, Nigeria.
    Okechukwu AA; Okechukwu OI
    Niger J Clin Pract; 2011; 14(2):206-11. PubMed ID: 21860141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased risk of severe infant anemia after exposure to maternal HAART, Botswana.
    Dryden-Peterson S; Shapiro RL; Hughes MD; Powis K; Ogwu A; Moffat C; Moyo S; Makhema J; Essex M; Lockman S
    J Acquir Immune Defic Syndr; 2011 Apr; 56(5):428-36. PubMed ID: 21266910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An open randomized controlled trial of zidovudine plus lamivudine versus stavudine plus lamivudine.
    Foudraine NA; de Jong JJ; Jan Weverling G; van Benthem BH; Maas J; Keet IP; Jurriaans S; Roos MT; Vandermeulen K; de Wolf F; Lange JM
    AIDS; 1998 Aug; 12(12):1513-9. PubMed ID: 9727573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A prospective study of haematological changes after switching from stavudine to zidovudine-based antiretroviral treatment in HIV-infected children.
    Singh A; Hemal A; Agarwal S; Dubey NK; Buxi G
    Int J STD AIDS; 2016 Nov; 27(13):1145-1152. PubMed ID: 24516076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of Severe Anemia and Changes in Hemoglobin in a Cohort of HIV-Infected Ugandan Adults Receiving Zidovudine-, Stavudine-, and Tenofovir-Containing Antiretroviral Regimens.
    Parkes-Ratanshi R; Katende D; Levin J; Wakeham K; Heiner G; Kamali A; Lalloo DG
    J Int Assoc Provid AIDS Care; 2015; 14(5):455-62. PubMed ID: 25425638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence of anaemia among HIV-infected patients treated with highly active antiretroviral therapy.
    Curkendall SM; Richardson JT; Emons MF; Fisher AE; Everhard F
    HIV Med; 2007 Nov; 8(8):483-90. PubMed ID: 17944680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fat distribution and metabolic abnormalities in HIV-infected patients on first combination antiretroviral therapy including stavudine or zidovudine: role of physical activity as a protective factor.
    Domingo P; Sambeat MA; Pérez A; Ordoñez J; Rodriguez J; Vázquez G
    Antivir Ther; 2003 Jun; 8(3):223-31. PubMed ID: 12924539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.
    Siegfried N; van der Merwe L; Brocklehurst P; Sint TT
    Cochrane Database Syst Rev; 2011 Jul; (7):CD003510. PubMed ID: 21735394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of malaria and anaemia among HIV infected pregnant women receiving co-trimoxazole prophylaxis in Tanzania: a cross sectional study in Kinondoni Municipality.
    Manyanga VP; Minzi O; Ngasala B
    BMC Pharmacol Toxicol; 2014 Apr; 15():24. PubMed ID: 24761799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The clinical features of paediatric HIV/AIDS at presentation at the University of Abuja Teaching Hospital, Gwagwalada.
    Okechukwu AA; Gambo D; Okechukwu OI
    Niger J Med; 2008; 17(4):433-8. PubMed ID: 19048762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of incidence of zidovudine induced anemia in Indian human immunodeficiency virus positive patients in comparison with stavudine based highly active antiretroviral therapy.
    Rajesh R; Vidyasagar S; Varma DM; Mohiuddin S; Noorunnisa
    Int J Risk Saf Med; 2011; 23(3):171-80. PubMed ID: 22020397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety of zidovudine dose reduction in treatment-naïve HIV infected patients. A randomized controlled study (MiniZID).
    Rougemont M; Nchotu Ngang P; Stoll B; Delhumeau C; Hill A; Ciaffi L; Bonnet F; Menga G; Fampou JC; Calmy A
    HIV Med; 2016 Mar; 17(3):206-15. PubMed ID: 26354678
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.